Pharma & Healthcare – the latest on FDA’s proposed generic drug labeling rule, FDA bans imports from India’s Sun Pharma and more.
$4 billion price tag? FDA’s proposed generic drug labeling rule by Erin M. Bosman, Sara Bradley, James W. Huston, Julie Y. Park & Jessica Roberts Published on jdsupra
An economic consulting group recently published findings that a Food and Drug Administration (FDA) proposed rule will increase annual healthcare costs by $4 billion… [ Read More ]
Pharma companies diverge in search for corporate health by Nick Kostov Published on Financial News
We expect pharmaceutical companies to research cures for our ailments. To judge by the feverish merger and acquisitions activity in the sector, however, they can feel financial maladies of their own coming on and are urgently seeking a remedy… [ Read More ]
FDA Bans Some Imports From India’s Sun Pharma; Shares Plunge by Ketaki Gokhale Published on Bloomberg
The Food and Drug Administration banned imports from a plant operated by Mumbai-based Sun Pharmaceutical Industries Ltd. (SUNP) amid widening scrutiny of Indian drugmakers that feed the $93 billion U.S. generics market… [ Read More ]
Live Industry News
Join ACI Pharmaceuticals/Biotech/Life Sciences Experts Group
Join ACI Healthcare: Legal, Regulatory, and Compliance Experts Group
Related Events
For the complete list of all Pharma upcoming events: Click Here
For the complete list of all Healthcare upcoming events: Click Here
For download past Pharma conference materials: Click Here
For download past Healthcare conference materials: Click Here